Point72 (DIFC)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$114K Sell
14,715
-5,504
-27% -$38.6K 0.01% 554
2025
Q2
$148K Buy
+20,219
New +$163K 0.01% 843
2024
Q2
Sell
-2,596
Closed -$40.8K 1759
2024
Q1
$40.8K Buy
+2,596
New +$40.1K ﹤0.01% 1228

Other funds holding NEO

Point72 (DIFC)'s NEO Position: Q3 2025 in Review

Point72 (DIFC) reduced its NeoGenomics (NEO) stake by 27% in Q3 2025, selling an estimated $38.6K and leaving 14,715 shares worth $114K. The position accounts for 0.01% of the portfolio, ranked #554.

Point72 (DIFC) first reported a position in NEO in Q1 2024 and has held it in 3 quarters since. The position peaked at $148K in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Point72 (DIFC) held 14,715 shares of NeoGenomics worth $114K as of Q3 2025.
  • Point72 (DIFC) sold 5,504 NeoGenomics shares in Q3 2025, an estimated $38.6K.
  • NeoGenomics made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #554 holding.
  • Point72 (DIFC) first reported a position in NeoGenomics in Q1 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s NeoGenomics position peaked at $148K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.